American Journal of Cardiology
Volume 106, Issue 3 , Pages 305-309 , 1 August 2010

Impact of Chronic Obstructive Pulmonary Disease on Acute-Phase Outcome of Myocardial Infarction

Received 22 January 2010 ,Revised 4 March 2010 ,Accepted 4 March 2010.

References 

  1. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128:2068–2075
  2. Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction. Eur J Heart Fail. 2009;11:292–298
  3. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol. 2007;99:636–641
  4. Kjøller E, Køber L, Iversen K, Torp-Pedersen C Trace Study Group. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail. 2004;6:71–77
  5. Behar S, Panosh A, Reicher-Reiss H, Zion M, Schlesinger Z, Goldbourt U. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction (SPRINT Study Group). Am J Med. 1992;93:637–641
  6. Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5:543–548
  7. Rusinaru D, Saaidi I, Godard S, Mahjoub H, Battle C, Tribouilloy C. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol. 2008;101:353–358
  8. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127:1952–1959
  9. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59:574–580
  10. Lee TM, Lin MS, Chang NC. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol. 2008;101:530–535
  11. Han MK, McLaughlin VV, Criner GJ, Martinez FJ. Pulmonary diseases and the heart. Circulation. 2007;116:2992–3005
  12. Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med. 2000;343:1902–1909
  13. Enson Y, Guintini C, Lewis ML, Morris TQ, Ferrer MI, Harvey RM. The influence of hydrogen ion concentration and hypoxia on the pulmonary circulation. J Clin Invest. 1964;43:1146–1162
  14. Durand J, Leroy-Ladurie M, Ransom-Bitker B. Effects of hypoxia and hypercapnia on the repartition of pulmonary blood flow in supine subjects. Respir Res. 1970;5:156–165
  15. MacIntyre NR. Mechanisms of functional loss in patients with chronic lung disease. Respir Care. 2008;53:1177–1184
  16. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med. 1999;159:S1–S40
  17. Gao D, Grunwald GK, Rumsfeld JS, Mackenzie T, Grover FL, Perlin JB, et al. Variation in mortality risk factors with time after coronary artery bypass graft operation. Ann Thorac Surg. 2003;75:74–81
  18. Selvaraj CL, Gurm HS, Gupta R, Ellis SG, Bhatt DL. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2005;96:756–759

PII: S0002-9149(10)00775-7

doi: 10.1016/j.amjcard.2010.03.026

American Journal of Cardiology
Volume 106, Issue 3 , Pages 305-309 , 1 August 2010

Article Tools

* Image Usage & Resolution